Oxazolone colitis, a Th2 colitis model resembling ulcerative colitis, is mediated by IL-13-producing NK-T cells

Immunity

Volumn 17, Issue 5, 2002, Pages 629-638

  Heller, Frank ^a   Fuss, Ivan J ^a   Nieuwenhuis, Edward E ^b,c   Blumberg, Richard S ^b   Strober, Warren ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c ROYAL NETHERLANDS ACADEMY OF ARTS AND SCIENCES   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GALACTOSYLCERAMIDE; INTERLEUKIN 13; INTERLEUKIN 13 RECEPTOR; OXAZOLONE; RECEPTOR SUBUNIT; T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTATION; ANTIGEN SPECIFICITY; ARTICLE; CELL SECRETION; CONTROLLED STUDY; CYTOKINE PRODUCTION; LYMPHOCYTE ACTIVATION; MALE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; TH2 CELL; ULCERATIVE COLITIS;

EID: 0036850908     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(02)00453-3     Document Type: Article

References (49)

1. Balk S.P., Bleicher P.A., Terhorst C. Isolation and characterization of a cDNA and gene coding for a fourth CD1 molecule. Proc. Natl. Acad. Sci. USA. 86:1989;252-256.
2. Bendelac A. Positive selection of mouse NK1+ T cells by CD1-expressing cortical thymocytes. J. Exp. Med. 182:1995;2091-2096.
3. Bleicher P.A., Balk S.P., Hagen S.J., Blumberg R.S., Flotte T.J., Terhorst C. Expression of murine CD1 on gastrointestinal epithelium. Science. 250:1990;679-682.
4. Blumberg R.S., Terhorst C., Bleicher P., McDermott F.V., Allan C.H., Landau S.B., Trier J.S., Balk S.P. Expression of a nonpolymorphic MHC class I-like molecule, CD1D, by human intestinal epithelial cells. J. Immunol. 147:1991;2518-2524.
5. Boirivant M., Fuss I.J., Chu A., Strober W. Oxazolone colitis. a murine model of T helper cell type 2 colitis treatable with antibodies to interleukin 4 J. Exp. Med. 188:1998;1929-1939.
6. Brown M.A., Hural J. Functions of IL-4 and control of its expression. Crit. Rev. Immunol. 17:1997;1-32.
7. Ceponis P.J., Botelho F., Richards C.D., McKay D.M. Interleukins 4 and 13 increase intestinal epithelial permeability by a phosphatidylinositol 3-kinase pathway. Lack of evidence for STAT 6 involvement. J. Biol. Chem. 275:2000;29132-29137.
8. Chen H., Paul W.E. Cultured NK1.1+ CD4+ T cells produce large amounts of IL-4 and IFN-gamma upon activation by anti-CD3 or CD1. J. Immunol. 159:1997;2240-2249.
9. Cui J., Shin T., Kawano T., Sato H., Kondo E., Toura I., Kaneko Y., Koseki H., Kanno M., Taniguchi M. Requirement for Vα14 NKT cells in IL-12-mediated rejection of tumors. Science. 278:1997;1623-1626.
10. Donaldson D.D., Whitters M.J., Fitz L.J., Neben T.Y., Finnerty H., Henderson S.L., O'Hara R.M. Jr., Beier D.R., Turner K.J., Wood C.R., Collins M. The murine IL-13 receptor alpha 2. molecular cloning, characterization, and comparison with murine IL-13 receptor alpha 1 J. Immunol. 161:1998;2317-2324.
11. Eberl G., MacDonald H.R. Rapid death and regeneration of NKT cells in anti-CD3epsilon- or IL-12-treated mice. a major role for bone marrow in NKT cell homeostasis Immunity. 9:1998;345-353.
12. Fiorentino D.F., Zlotnik A., Vieira P., Mosmann T.R., Howard M., Moore K.W., O'Garra A. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J. Immunol. 146:1991;3444-3451.
13. Fort M.M., Cheung J., Yen D., Li J., Zurawski S.M., Lo S., Menon S., Clifford T., Hunte B., Lesley R.et al. IL-25 induces IL-4, IL-5, and IL-13 and Th2-associated pathologies in vivo. Immunity. 15:2001;985-995.
14. Fuss I.J., Neurath M., Boirivant M., Klein J.S., de la Motte C., Strong S.A., Fiocchi C., Strober W. Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5. J. Immunol. 157:1996;1261-1270.
15. Grunig G.G., Warnock M., Wakil A.E., Venkayya R., Brombacher F., Rennick D.M., Sheppard D., Mohrs M., Donaldson D., Locksley R.M., Corry D.B. Requirements for IL-13 independently of IL-4 in experimental asthma. Science. 282:1998;2160-2163.
16. Gumperz J.E., Roy C., Makowska A., Lum D., Sugita M., Podrebarac T., Koezuka Y., Porcelli S.A., Cardell S., Brenner M.B., Behar S.M. Murine CD1d-restricted T cell recognition of cellular lipids. Immunity. 12:2000;211-221.
17. Hameg A., Gouarin C., Gombert J.M., Hong S., Van Kaer L., Bach J.F., Herbelin A. IL-7 upregulates IL-4 production by splenic NK1.1 and NK1.1-MHC class I-like/CD1-dependent CD4+ T cells. J. Immunol. 162:1999;7067-7074.
18. Hayakawa K., Lin B.T., Hardy R.R. Murine thymic CD4+ T cell subsets. a subset (Thy0) that secretes diverse cytokines and overexpresses the V beta 8 T cell receptor gene family J. Exp. Med. 176:1992;269-274.
19. Ishikawa H., Hisaeda H., Taniguchi M., Nakayama T., Sakai T., Maekawa Y., Nakano Y., Zhang M., Zhang T., Nishitani M.et al. CD4(+) v(alpha)14 NKT cells play a crucial role in an early stage of protective immunity against infection with Leishmania major. Int. Immunol. 12:2000;1267-1274.
20. Kaneko Y., Harada M., Kawano T., Yamashita M., Shibata Y., Gejyo F., Nakayama T., Taniguchi M. Augmentation of Vα14 NKT cell-mediated cytotoxicity by interleukin 4 in an autocrine mechanism resulting in the development of concanavalin A-induced hepatitis. J. Exp. Med. 191:2000;105-114.
21. Kawano T., Cui J., Koezuka Y., Toura I., Kaneko Y., Motoki K., Ueno H., Nakagawa R., Sato H., Kondo E.et al. CD1d-restricted and TCR-mediated activation of vα14 NKT cells by glycosylceramides. Science. 278:1997;1626-1629.
22. Koyasu S. CD3+CD16+NK1.1+B220+ large granular lymphocytes arise from both alpha-beta TCR+CD4-CD8- and gamma-delta TCR+CD4-CD8- cells. J. Exp. Med. 179:1994;1957-1972.
23. Kumar H., Belperron A., Barthold S.W., Bockenstedt L.K. Cutting edge. CD1d deficiency impairs murine host defense against the spirochete, Borrelia burgdorferi J. Immunol. 165:2000;4797-4801.
24. Lantz O., Bendelac A. An invariant T cell receptor alpha chain is used by a unique subset of major histocompatibility complex class I-specific CD4+ and CD4-8- T cells in mice and humans. J. Exp. Med. 180:1994;1097-1106.
25. Lee P.T., Benlagha K., Teyton L., Bendelac A. Distinct functional lineages of human V(alpha)24 natural killer T cells. J. Exp. Med. 195:2002;637-641.
26. Minty A., Asselin S., Bensussan A., Shire D., Vita N., Vyakarnam A., Wijdenes J., Ferrara P., Caput D. The related cytokines interleukin-13 and interleukin-4 are distinguished by differential production and differential effects on T lymphocytes. Eur. Cytokine Netw. 8:1997;203-213.
27. Miyamoto K., Miyake S., Yamamura T. A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells. Nature. 413:2001;531-534.
28. Mizoguchi A., Mizoguchi E., Bhan A.K. The critical role of interleukin 4 but not interferon gamma in the pathogenesis of colitis in T-cell receptor alpha mutant mice. Gastroenterology. 116:1999;320-326.
29. Moore K.W., O'Garra A., de Waal Malefyt R., Vieira P., Mosmann T.R. Interleukin-10. Annu. Rev. Immunol. 11:1993;165-190.
30. Neurath M.F., Fuss I., Kelsall B.L., Stuber E., Strober W. Antibodies to interleukin 12 abrogate established experimental colitis in mice. J. Exp. Med. 182:1995;1281-1290.
31. Park S.H., Roark J.H., Bendelac A. Tissue-specific recognition of mouse CD1 molecules. J. Immunol. 160:1998;3128-3134.
32. Parronchi P., Romagnani P., Annunziato F., Sampognaro S., Becchio A., Giannarini L., Maggi E., Pupilli C., Tonelli F., Romagnani S. Type 1 T-helper cell predominance and interleukin-12 expression in the gut of patients with Crohn's disease. Am. J. Pathol. 150:1997;823-832.
33. Roark J.H., Park S.H., Jayawardena J., Kavita U., Shannon M., Bendelac A. CD1.1 expression by mouse antigen-presenting cells and marginal zone B cells. J. Immunol. 160:1998;3121-3127.
34. Sartor R.B. Current concepts of the etiology and pathogenesis of ulcerative colitis and Crohn's disease. Gastroenterol. Clin. North Am. 24:1995;475-507.
35. Saubermann L.J., Beck P., De Jong Y.P., Pitman R.S., Ryan M.S., Kim H.S., Exley M., Snapper S., Balk S.P., Hagen S.J.et al. Activation of natural killer T cells by alpha-galactosylceramide in the presence of CD1d provides protection against colitis in mice. Gastroenterology. 119:2000;119-128.
36. Scheiffele F., Fuss I. Induction of TNBS colitis in mice. Coligan J.E., Kruisbeek A.M., Margulies D.H., Shevach E.M., Strober W. Current Protocols in Immunology, Volume 4. 2002;15 John Wiley & Sons, Inc, New York. 19.Unit.
37. Smiley S.T., Kaplan M.H., Grusby M.J. Immunoglobulin E production in the absence of interleukin-4-secreting CD1-dependent cells. Science. 275:1997;977-979.
38. Sonoda K.H., Exley M., Snapper S., Balk S.P., Stein-Streilein J. CD1-reactive natural killer T cells are required for development of systemic tolerance through an immune-privileged site. J. Exp. Med. 190:1999;1215-1226.
39. Spada F.M., Koezuka Y., Porcelli S.A. CD1d-restricted recognition of synthetic glycolipid antigens by human natural killer T cells. J. Exp. Med. 188:1998;1529-1534.
40. Spada F.M., Borriella F., Sugita M., Watts G.F., Koezuka Y., Porcelli S.A. Low expression level but potent antigen presenting functions of CD1d on monocyte lineage cells. Eur. J. Immunol. 30:2000;3468-3477.
41. Strober S., Cheng L., Zeng D., Palathumpat R., Dejbakhsh-Jones S., Huie P., Sibley R. Double negative (CD4-CD8- alpha beta+) T cells which promote tolerance induction and regulate autoimmunity. Immunol. Rev. 149:1996;217-230.
42. Takeda K., Hayakawa Y., Van Kaer L., Matsuda H., Yagita H., Okumura K. Critical contribution of liver natural killer T cells to a murine model of hepatitis. Proc. Natl. Acad. Sci. USA. 97:2000;5498-5503.
43. Terabe M., Matsui S., Noben-Trauth N., Chen H., Watson C., Donaldson D.D., Carbone D.P., Paul W.E., Berzofsky J.A. NKT cell-mediated repression of tumor immunosurveillance by IL-13 and the IL-4R-STAT6 pathway. Nat. Immunol. 1:2000;515-520.
44. Urban J.F. Jr., Noben-Trauth N., Donaldson D.D., Madden K.B., Morris S.C., Collins M., Finkelman F.D. IL-13, IL-4Rα, and Stat6 are required for the expulsion of the gastrointestinal nematode parasite Nippostrongylus brasiliensis. Immunity. 8:1998;255-264.
45. Vezys V., Olson S., Lefrancois L. Expression of intestine-specific antigen reveals novel pathways of CD8 T cell tolerance induction. Immunity. 12:2000;505-514.
46. Wills-Karp M., Luyimbazi J., Xu X., Schofield B., Neben T.Y., Karp C.L., Donaldson D.D. Interleukin-13. central mediator of allergic asthma Science. 282:1998;2258-2261.
47. Yoshimoto T., Paul W.E. CD4pos, NK1.1pos T cells promptly produce interleukin 4 in response to in vivo challenge with anti-CD3. J. Exp. Med. 179:1994;1285-1295.
48. Zhang Y., Rogers K.H., Lewis D.B. Beta 2-microglobulin dependent T cells are dispensable for allergen-induced T helper 2 response. J. Exp. Med. 184:1996;1507-1512.
49. Zurawski G., de Vries J.E. Interleukin 13, an interleukin 4-like cytokine that acts on monocytes and B cells, but not on T cells. Immunol. Today. 15:1994;19-26.